3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Breast Neoplasms
37
Carcinoma, Non-Small-Cell Lung
28
Glioblastoma
24
Brain Neoplasms
23
Esophageal Neoplasms
20
Rectal Neoplasms
19
Stomach Neoplasms
17
Glioma
17
Lung Neoplasms
16
Colorectal Neoplasms
16
Astrocytoma
14
Pancreatic Neoplasms
12
Central Nervous System Neoplasms
12
Squamous Cell Carcinoma of Head and Neck
10
Neoplasm Metastasis
10
Head and Neck Neoplasms
10
Gliosarcoma
10
Sarcoma
9
Oligodendroglioma
9
Recurrence
8
Neoplasms
8
Adenocarcinoma Of Esophagus
8
Esophageal Squamous Cell Carcinoma
7
Uterine Cervical Neoplasms
6
Ovarian Neoplasms
6
Colonic Neoplasms
6
Pilonidal Sinus
5
Melanoma
5
Carcinoma, Ovarian Epithelial
5
Adenocarcinoma of Lung
5
Interventions
pembrolizumab
6
Nivolumab
6
Ipilimumab
4
Radiotherapy
3
talimogene laherparepvec
2
budigalimab
2
avelumab
2
atezolizumab
2
Everolimus
2
Cyclophosphamide
2
zimberelimab
1
venetoclax
1
vatalanib
1
tremelimumab
1
temsirolimus
1
sapanisertib
1
rovalpituzumab tesirine
1
poly ICLC
1
oblimersen
1
lorvotuzumab mertansine
1
lanreotide
1
glucopyranosyl lipid-A
1
fludarabine
1
durvalumab
1
domatinostat
1
cixutumumab
1
cemiplimab
1
aldesleukin
1
Vinorelbine
1
Surgical Procedures, Operative
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Carcinoma, Merkel Cell
×
Surgical Procedures, Operative
×
Clear all
NCT05253144
2024-05-08
Rational-MCC
University of Birmingham
Phase NA
Completed
64 enrolled